Teladoc Health Inc reports results for the quarter ended March 31 - Earnings Summary

Teladoc Health

30/04/2025 22:02

Teladoc Health Inc TDOC.N reported a quarterly adjusted loss of 53 cents​​ per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of -49 cents.  The mean expectation of twenty five analysts for the quarter was for a loss of 34 cents per share. Wall Street expected results to range from -42 cents to -26 cents per share.

Revenue fell 2.6% to $629.37 million from a year ago; analysts expected $619.20 million.

Teladoc Health Inc's reported EPS for the quarter was a loss of 53 cents​.

The company reported a quarterly loss of $93.01 million.

Teladoc Health Inc shares had fallen by 7.9% this quarter and lost 19.4% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 8.2% in the last three months.​

In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 5 "strong buy" or "buy," 21 "hold" and no "sell" or "strong sell." The average consensus recommendation for the healthcare facilities & services peer group is also "hold"

Wall Street's median 12-month price target for Teladoc Health Inc is $9.00

This summary was machine generated from LSEG data April 30 at 09:02 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Mar. 31 2025
-0.34
-0.53
Missed
Dec. 31 2024
-0.24
-0.28
Missed
Sep. 30 2024
-0.28
-0.19
Beat
Jun. 30 2024
-0.35
-0.28
Beat